2009 Publications

  • Anandacoomarasaamy A, Smith G, Leibman S, Caterson I, Guffrie B, Fransen M, Sambrook P, March L: Cartilage defects are associated with physical disability in obese adults. Rheumatology. 48: 1290-1293, 2009
  • Chen C, March L, Cumming RG, Cameron ID, Simpson JM, Lord SR, Sambrook PN: Role of quantitative ultrasound to predict fracture among institutionalised older people with a history of fracture. Osteoporosis Int. 20: 105-112, 2009
  • Chen JS, Hogan JC, Lyubomirsky, Sambrook PN: Management of osteoporosis in primary care in Australia. Osteoporosis Int. 20: 491-496, 2009
  • Combe B, Codreanu C, Fiocco U, Gaubitz M, Geusens PP, Kvien TK, Pavelka K, Sambrook PN, Smolen JS, Khandker R, Singh A, Wajdula J, Fatenejad S: Efficacy, safety, and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double blind study. Ann Rheum Dis. 68: 1146-1152, 2009
  • Cranney A, Wells GA, Yestisir L, Adami C, Cooper C, Delmas P, Miller P, Papadoulos, Reginster JY, Sambrook P, Silverman P, Siris E, Adachi R: Ibandronate for the prevention of non-vertebral fractures: a pooled analysis of individual patient data. Osteoporosis Int. 20: 291-298, 2009
  • Hooven FH, Adachi JD, Adami S, Boonen S, Comptson J, Cooper C, Delmas P, Diez-Perez A, Gehlbach S, Greenspan SL, LaCroix A, Lindsay R, Coen Netelenbos J, Pfeilschifter J, Roux C, Saag KG, Sambrook PN, Silverman S, Siris E, Watts NB, Anderson F: The Global Study of Osteoporosis in Women (GLOW); rationale and study design. Osteoporosis Int. 20: 1107-1116, 2009
  • Jackson M, Smith MM, Smith SM, Xue M, Jackson C, Little CB: The role of activated protein C (APC) in MMP activation and collagenolysis in cartilage. Arthritis Rheum. 60:780-91, 2009
  • Kok C, Sambrook P: Secondary osteoporosis in patients with an osteoporotic fracture. Best Prac Res Clin Rheum. 23, 6: 769-779, 2009
  • Little CB, Barai A, Burkhardt D, Smith SM, Fosang AJ, Werb Z, Shah M, Thompson EW: Matrix metalloproteinase (MMP) 13 deficient mice are resistant to cartilage erosion but not osteophyte development in a surgical model of osteoarthritis. Arthritis Rheum. 60:3723-3733, 2009.
  • Makovey J, Chen JS, Hayward C, Williams FMK, Sambrook PN: Association between serum cholesterol and bone mineral density. Bone. 44: 208-213, 2009.
  • Melrose J, Burkhardt D, Smith SM, Read R, Cake M, Taylor TKF, Dillon C, Little CB: Calcification in the ovine intervertebral disc: a model of hydroxyapatite deposition disease. Eur Spine J. 18:479-89, 2009.
  • Miller MD, Thomas JM, Cameron ID, Chen JS, Sambrook PN, March LM, Cumming RG, Lord SR: BMI: a simple, rapid and clinically meaningful index of under-nutrition in the oldest old? Brit J Nutr. 101: 1300–1305, 2009
  • Reid DM, Devogelaer JP, Saag K, Roux C, Lau CS, Reginster JY, Papanastasiou P, Ferreira A, Hartl F, Fashola T, Mesenbrick, Sambrook PN: Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid induced osteoporosis: a multicentre, double bind, double dummy, randomized controlled trial. Lancet. 373: 1253-63, 2009
  • Sambrook PN, Schrieber L, Taylor T, Ellis A edit: Systems of the Body: The Musculoskeletal System., 2nd edition, Churchill Livingstone, Edinburgh, 2009
  • Sambrook PN: Consensus practice guidelines for bisphosphonate associated osteoonecrosis of the jaw. Nature Clin Pract Rheum. 5: 6-7, 2009
  • Sebba AL, Emkey RD, Kohles JD, Sambrook PN: Ibandronate dose response is accosiated with increases in bone mineral density and reductions in clinical fractures: results of a meta-analysis. Bone. 44: 423-427, 2009
  • Smith SM, Whitelock JM, Iozzo RV, Little CB, Melrose J: Topographical variation in the distributions of versican, aggrecan and perlecan in the foetal human spine reflects their diverse functional roles in spinal development. Histochem Cell Biol.132: 491-503, 2009
  • Xue A, Xue M, Jackson CJ and Smith RC: Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. Int J Biochem Cell Biol. 41 8-9: 1731-1738, 2009
  • Xue M, Smith M, Little C, Sambrook P, March L, Jackson CJ: Activated protein C mediates a healing phenotype in cultured tenocytes. J Cell Mol Med. 13: 749-757, 2009